Are Sirius Minerals and CloudTag top buys after this month’s financing deals?

Should you load up on Sirius Minerals and CloudTag today?

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Popular AIM stocks Sirius Minerals (LSE: SXX) and CloudTag (LSE: CTAG) have both announced financing deals this month. But with their shares currently trading well below previous highs, is now the time for canny investors to buy a slice of these two businesses?

Sirius on track

Sirius is set to begin construction of its North Yorkshire potash mine having announced comprehensive funding for Stage 1 of its two-stage funding requirement.

Back in the summer, at a share price of 26.5p and market cap of £611m, I reckoned the equity component of the funding would be around £400m, giving a prospective market cap of just over £1bn. I rated the stock a speculative buy based on the £1bn valuation and projected annual revenues of $3bn (£2.4bn).

The equity component has turned out to be £370m via a placing and open offer at 20p. But there’s also a future $50m share issue at 20p (part of a $300m royalty financing deal with Australian mining magnate Gina Rinehart) and a $400m convertible bond issue with a conversion price of 25p.

Taking all this into account, the prospective diluted market cap is about £1.2bn at a current share price of 21p. So, the funding has been somewhat more generous to the new investors than I envisaged. However, risk has reduced through securing the Stage 1 funding, Stage 2 is expected to be via senior debt and a valuation of 0.5 times projected annual revenues offers some protection against any unexpected further equity dilution before first production in 2021. As such, I continue to believe the stock is an attractive buy.

CloudTag off track

Wearable technology firm CloudTag (LSE: CTAG) started 2016 with a bang, announcing the launch of its first product (a fitness tracker) and a commercial contract with distributor Second Chance that would “guarantee” minimum sales of $5.2m by year-end.

In early June, CloudTag said Second Chance “is now concluding initial product delivery requirements” with 11 retailers — unnamed but in most cases readily identifiable: for example, “the largest employee-owned UK department store” (John Lewis) and “Europe’s largest retailer for consumer electronics, with over 700 Stores in 14 countries” (Media Markt).

On 7 November, CloudTag announced that “no firm purchase orders have as yet been received from Second Chance or otherwise” and that the minimum $5.2m of orders by year-end “is now unlikely to be achieved”.

In the same announcement, CloudTag said it intended to raise £4m by issuing convertible notes to “an overseas Institutional Investor.” In contrast to Sirius’s conventional convertibles issue — in which conversion is based on a fixed price — CloudTag’s is based on a fluctuating market price. Indeed, CloudTag’s deal has several hallmarks of what, in the words of the US Securities & Exchange Commission, “have colloquially been called ‘floorless’, ‘toxic,’ ‘death spiral,’ and ‘ratchet’ convertibles”. Such deals are rarely good news for shareholders.

At a price of 11.2p in early trading today and with 379,295,962 shares in issue, CloudTag has a market cap of £42m. The company isn’t short of enthusiastic supporters but for me this is a stock to avoid due to:

  • The ‘guaranteed’ sales that weren’t in truth guaranteed.
  • The lack of a single firm order more than 10 months after commercial launch and five months after Second Chance was “now concluding” initial orders with multiple major retailers.
  • The low-grade financing deal.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

G A Chester has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Warren Buffett at a Berkshire Hathaway AGM
Investing Articles

This 1 simple investing move accelerated Warren Buffett’s wealth creation

Warren Buffett has used this easy to understand investing technique for decades -- and it has made him billions. Our…

Read more »

Young woman working at modern office. Technical price graph and indicator, red and green candlestick chart and stock trading computer screen background.
Investing Articles

Down 6% in 2 weeks, the Lloyds share price is in reverse

After hitting a one-year high on 8 April, the Lloyds share price has suddenly reversed course. But as a long-term…

Read more »

Investing Articles

£3,000 in savings? Here’s how I’d use that to start earning a monthly passive income

Our writer digs into the details of how spending a few thousand pounds on dividend shares now could help him…

Read more »

Investing Articles

Here’s what dividend forecasts could do for the BP share price in the next three years

I can understand why the BP share price is low, as oil's increasingly seen as evil. But BP's a cash…

Read more »

Man writing 'now' having crossed out 'later', 'tomorrow' and 'next week'
Investing Articles

This FTSE 100 Dividend Aristocrat is on sale now

Stephen Wright thinks Croda International’s impressive dividend record means it could be the best FTSE 100 stock to add to…

Read more »

Investing Articles

3 shares I’d buy for passive income if I was retiring early

Roland Head profiles three FTSE 350 dividend shares he’d like to buy for their passive income to support an early…

Read more »

Investing Articles

Here’s how many Aviva shares I’d need for £1,000 a year in passive income

Our writer has been buying shares of this FTSE 100 insurer, but how many would he need to aim for…

Read more »

Female Doctor In White Coat Having Meeting With Woman Patient In Office
Investing Articles

1 incredible growth stock I can’t find on the FTSE 100

The FTSE 100 offers us a lot of interesting investment opportunities, but there's not much in the way of traditional…

Read more »